Catheter Precision
VTAK
8 hedge funds and large institutions have $904K invested in Catheter Precision in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.
92% more capital invested
Capital invested by funds: $470K → $904K (+$435K)
0.04% more ownership
Funds ownership: 0.02% → 0.06% (+0.04%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
11% less funds holding
Funds holding: 9 → 8 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$1.42M |
| 2 |
Renaissance Technologies
New York
|
+$115K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$43.5K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$9.78K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$101K |
| 2 |
Goldman Sachs
New York
|
-$91.2K |
| 3 |
Morgan Stanley
New York
|
-$47.5K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$30.5K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$543 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $762K | +$1.42M | +2,621 | New |
|
|
2
Renaissance Technologies
New York
| $62K | +$115K | +212 | New |
|
3
BlackRock
New York
| $28.2K | – | – | – |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $23.4K | +$43.5K | +80 | New |
|
|
5
Geode Capital Management
Boston,
Massachusetts
| $20.4K | -$543 | -1 | -1% |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $8K | +$9.78K | +18 | +200% |
|
|
FDCDDQ
7
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $306 | – | – | – |
|
8
Osaic Holdings
Scottsdale,
Arizona
| $153 | – | – | – |
|
|
APC
9
Aspire Private Capital
Cornelius,
North Carolina
| $31 | – | – | – |
|
|
HI
10
Harbour Investments
Madison,
Wisconsin
| $31 | – | – | – |
|
11
Wells Fargo
San Francisco,
California
| $26 | – | – | – |
|
|
12
Citadel Advisors
Miami,
Florida
| – | -$101K | -90 | Closed |
|
|
13
Goldman Sachs
New York
| – | -$91.2K | -81 | Closed |
|
|
14
Morgan Stanley
New York
| – | -$47.5K | -42 | Closed |
|
|
15
UBS Group
Zurich,
Switzerland
| – | -$30.5K | -27 | Closed |
|
VTAK Hedge Fund Activity: Q1 2023 in Review
8 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q1 2023, worth a combined $904K — up 92% from $470K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of VTAK and 3 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Armistice Capital, opening a new position worth an estimated $1.42M. The largest seller was Citadel Advisors, exiting entirely with an estimated $101K sold.
- 8 institutional investors held Catheter Precision (VTAK) as of Q1 2023, down from 9 in Q4 2022.
- Funds reported $904K of Catheter Precision stock for Q1 2023, up 92% quarter-over-quarter.
- 3 funds opened new Catheter Precision positions in Q1 2023 and 4 closed out, a net change of -1 holder.
- The largest Catheter Precision buyer in Q1 2023 was Armistice Capital, an estimated $1.42M added.
- The largest Catheter Precision seller in Q1 2023 was Citadel Advisors, an estimated $101K sold.
Based on aggregated 13F filings for Q1 2023.